retatrutide weight loss clinical trials retatrutide Retatrutide, the next generation of GLP-1 drug from Eli Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage trial, the company announced. In New Weight Loss Drug Retatrutide:

These GI health problems could be fatal without urgent medical attention

Understanding retatrutides risks to the gallbladder assists both users and health providers in making more informed decisions

And oral small-molecule agents have a lot of advantages

And if youve been working on your nutrition, showing up to your workouts, prioritizing protein, trying to be consistent, it can start to feel like youre doing all of the right things, but moving much more slowly and it can feel like youre behind

Rondinone CM, Valdecantos P, Rada P, Valverde AM, Ghosh S (2024) Novel unimolecular tetra-agonist peptides targeting GLP-1, GIP, amylin, and calcitonin receptors with enhanced metabolic benefits in animal models of obesity